The effects of C-terminal modifications on the opioid activity of [N-benzylTyr1]dynorphin A-(1-11) analogues

Journal of Medicinal Chemistry

Volumn 52, Issue 21, 2009, Pages 6814-6821

  Patkar, Kshitij A ^a   Murray, Thomas F ^b   Aldrich, Jane V ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; DYNORPHIN A (1-11) DERIVATIVE; DYNORPHIN A DERIVATIVE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; OPIATE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CYCLIZATION; DRUG EFFICACY; DRUG SYNTHESIS; SOLID PHASE SYNTHESIS;

ADENYLATE CYCLASE; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; DYNORPHINS; LIGANDS; MICE; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PEPTIDES, CYCLIC; RADIOLIGAND ASSAY; RATS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 71049131594     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm900715m     Document Type: Article

References (49)

1. Trescot, A. M.; Glaser, S. E.; Hansen, H.; Benyamin, R.; Patel, S.; Manchikanti, L. Effectiveness of Opioids in the Treatment of Chronic Noncancer Pain. Pain Physician 2008, 11, S181-200. (Pubitemid 351682085)
2. Benyamin, R.; Trescot, A. M.; Datta, S.; Buenaventura, R.; Adlaka, R.; Sehgal, N.; Glaser, S. E.; Vallejo, R. Opioid Complications and Side Effects. Pain Physician 2008, 11, S105-120.
3. Aldrich, J. V.; Vigil-Cruz, S. Narcotic Analgesics. In Burger's Medicinal Chemistry and Drug Discovery, 6th ed.; Abraham, D., Ed.; John Wiley & Sons, Inc.: New York, 2003; Vol.6, pp 329-481.
4. Millan, M. J. Kappa-Opioid Receptors and Analgesia. Trends Pharmacol. Sci. 1990, 11, 70-76.
5. Park, H. S.; Lee, H. Y.; Kim, Y. H.; Park, J. K.; Zvartau, E. E.; Lee, H. A Highly Selective Kappa-Opioid Receptor Agonist with Low Addictive Potential and Dependence Liability. Bioorg. Med. Chem. Lett. 2006, 16, 3609-3613.
6. Pfeiffer, A.; Brantl, V.; Herz, A.; Emrich, H. M. Psychotomimesis Mediated by Kappa Opiate Receptors. Science 1986, 233, 774-776.
7. DeHaven-Hudkins, D. L.; Dolle, R. E. Peripherally Restricted Opioid Agonists as Novel Analgesic Agents. Curr. Pharm. Des. 2004, 10, 743-757.
8. Vanderah, T. W.; Largent-Milnes, T.; Lai, J.; Porreca, F.; Houghten, R. A.; Menzaghi, F.; Wisniewski, K.; Stalewski, J.; Sueiras-Diaz, J.; Galyean, R.; Schteingart, C.; Junien, J. L.; Trojnar, J.; Riviere, P. J. Novel D-Amino Acid Tetrapeptides Produce Potent Antinociception by Selectively Acting at Peripheral Kappa-Opioid Receptors. Eur. J. Pharmacol. 2008, 583, 62-72.
9. Walker, J. S. Anti-inflammatory Effects of Opioids. Adv. Exp. Med. Biol. 2003, 521, 148-160.
10. Aldrich, J. V.; McLaughlin, J. P. Peptide Kappa Opioid Receptor Ligands: Potential for Drug Development. AAPS J. 2009, 11, 312-322.
11. Mague, S. D.; Pliakas, A. M.; Todtenkopf, M. S.; Tomasiewicz, H. C.; Zhang, Y.; Stevens, W. C., Jr; Jones, R. M.; Portoghese, P. S.; Carlezon, W. A., Jr. Antidepressant-like Effects of Kappa-Opioid Receptor Antagonists in the Forced Swim Test in Rats. J. Pharmacol. Exp. Ther. 2003, 305, 323-330.
12. Beardsley, P. M.; Howard, J. L.; Shelton, K. L.; Carroll, F. I. Differential Effects of the Novel Kappa Opioid Receptor Antagonist, JDTic, on Reinstatement of Cocaine-seeking Induced by Footshock Stressors vs Cocaine Primes and its Antidepressant-like Effects in Rats. Psychopharmacology (Berlin) 2005, 183, 118-126.
13. Zhang, H.; Shi, Y. G.; Woods, J. H.; Watson, S. J.; Ko, M. C. Central Kappa-Opioid Receptor-mediated Antidepressant-like Effects of nor-Binaltorphimine: Behavioral and BDNF mRNA Expression Studies. Eur. J. Pharmacol. 2007, 570, 89-96.
14. Knoll, A. T.; Meloni, E. G.; Thomas, J. B.; Carroll, F. I.; Carlezon, W. A., Jr. Anxiolytic-like Effects of Kappa-Opioid Receptor Antagonists in Models of Unlearned and Learned Fear in Rats. J. Pharmacol. Exp. Ther. 2007, 323, 838-845.
15. Wittmann, W.; Schunk, E.; Rosskothen, I.; Gaburro, S.; Singewald, N.; Herzog, H.; Schwarzer, C. Prodynorphin-derived Peptides are Critical Modulators of Anxiety and Regulate Neurochemistry and Corticosterone. Neuropsychopharmacology 2009, 34, 775-785.
16. Rothman, R. B.; Gorelick, D. A.; Heishman, S. J.; Eichmiller, P. R.; Hill, B. H.; Norbeck, J.; Liberto, J. G. An Open-label Study of a Functional Opioid Kappa Antagonist in the Treatment of Opioid Dependence. J. Subst. Abuse Treat. 2000, 18, 277-281.
17. Carey, A. N.; Borozny, K.; Aldrich, J. V.; McLaughlin, J. P. Reinstatement of Cocaine Place-conditioning Prevented by the Peptide Kappa-Opioid Receptor Antagonist Arodyn. Eur. J. Pharmacol. 2007, 569, 84-89.
18. Bennett, M. A.; Murray, T. F.; Aldrich, J. V. Identification of Arodyn, a Novel Acetylated Dynorphin A-(1-11) Analogue, as a Kappa Opioid Receptor Antagonist. J. Med. Chem. 2002, 45, 5617-5619.
19. Chavkin, C.; James, I. F.; Goldstein, A. Dynorphin is a Specific Endogenous Ligand of the κ Opioid Receptor. Science 1982, 215, 413-415.
20. Chavkin, C.; Goldstein, A. Specific Receptor for the Opioid Peptide Dynorphin: Structure-Activity Relationships. Proc. Natl. Acad. Sci. U.S.A. 1981, 78, 6543-6547.
21. 10]- dynorphin A(1-11). Br. J. Pharmacol. 1988, 95, 1023-1030.
22. Lemaire, S.; Parent, P.; Lapierre, C.; Michelot, R. N,N-Diallylated Analogs of Dynorphin A-(1-13) as Potent Antagonists for the Endogenous Peptide and Selective Kappa Opioid Analgesics. Prog. Clin. Biol. Res. 1990, 328, 45-48.
23. 10]dynorphin A-(1-11) are Highly Selective for Kappa-Opioid Receptors. J. Med. Chem. 1992, 35, 4638-4639.
24. 10]Dynorphin A-(1-11) Analogues with N-Terminal Alkyl Substitution. J. Med. Chem. 1997, 40, 2733-2739.
25. 10]dynorphin A-(1-11) are High Affinity Partial Agonists at the Cloned Rat Kappa-Opioid Receptor. Eur. J. Pharmacol. 1997, 338, 191-197.
26. 2: A Dynorphin Analogue with High Selectivity for the Kappa Opioid Receptor. J. Med. Chem. 2000, 43, 2698-2702.
27. 2 Analogues Lacking an N-Terminal Amino Group: Potent and Selective Kappa Opioid Antagonists. J. Med. Chem. 2001, 44, 3048-3053.
28. Wan, Q.; Murray, T. F.; Aldrich, J. V. A Novel Acetylated Analogue of Dynorphin A-(1-11) Amide as a Kappa-Opioid Receptor Antagonist. J. Med. Chem. 1999, 42, 3011-3013.
29. 2 that Lacks the Basic N-Terminus. J. Med. Chem. 2003, 46, 1279-1282.
30. Kawasaki, A.M.; Knapp, R. J.;Walton, A.;Wire,W. S.; Zalewska, T.; Yamamura, H. I.; Porreca, F.; Burks, T. F.; Hruby, V. J. Syntheses, Opioid Binding Affinities, and Potencies of Dynorphin A Analogues Substituted in Positions, 1, 6, 7, 8, and 10. Int. J. Pept. Protein Res. 1993, 42, 411-419.
31. Naqvi, T.; Haq, W.; Mathur, K. B. Structure-Activity Relationship Studies of Dynorphin A and Related Peptides. Peptides 1998, 19, 1277-1292. (Pubitemid 28475133)
32. Meyer, J. P.; Collins, N.; Lung, F. D.; Davis, P.; Zalewska, T.; Porreca, F.; Yamamura, H. I.; Hruby, V. J. Design, Synthesis, and Biological Properties of Highly Potent Cyclic Dynorphin A Analogues. Analogues Cyclized between Positions 5 and 11. J. Med. Chem. 1994, 37, 3910-3917.
33. Arttamangkul, S.; Ishmael, J. E.; Murray, T. F.; Grandy, D. K.; DeLander,G. E.; Kieffer, B. L.; Aldrich, J. V. Synthesis and Opioid Activity of Conformationally Constrained Dynorphin A Analogues. 2. Conformational Constraint in the "Address" Sequence. J. Med. Chem. 1997, 40, 1211-1218.
34. Paterlini, G.; Portoghese, P. S.; Ferguson, D. M. Molecular Simulation of Dynorphin A-(1-10) Binding to Extracellular Loop 2 of the Kappa-Opioid Receptor. A Model for Receptor Activation. J. Med. Chem. 1997, 40, 3254-3262.
35. 2 Cyclized in the "Address" Domain is a Novel Kappa-Opioid Receptor Antagonist. J. Med. Chem. 2005, 48, 4500-4503..
36. Carpino, L. A.; El-Faham, A.; Minor, C. A.; Alberizio, F. Advantageous Application of Azabenzotriazole (Triazolopyridine)- Based Coupling Reagents to Solid-Phase Peptide Synthesis. J. Chem. Soc., Chem. Commun. 1994, 201-203.
37. Yue, C.; Thierry, J.; Potier, P. 2-Phenyl Isopropyl Esters as Carboxyl Terminus Protecting Groups in the Fast Synthesis of Peptide Fragments. Tetrahedron Lett. 1993, 34, 323-326. (Pubitemid 23024187)
38. Aletras, A.; Barlos, K.; Gatos, D.; Koutsogianni, S.; Mamos, P. Preparation of the Very Acid-sensitive Fmoc-Lys(Mtt)-OH. Application in the Synthesis of Side-Chain to Side-Chain Cyclic Peptides and Oligolysine Cores Suitable for the Solid-Phase Assembly of MAPs and TASPs. Int. J. Pept. Protein Res. 1995, 45, 488-496.
39. 8]-Dynorphin A. J. Org. Chem. 1992, 57, 5399-5403.
40. King, D. S.; Fields, C. G.; Fields, G. B. A Cleavage Method Which Minimizes Side Reactions Following Fmoc Solid Phase Peptide Synthesis. Int. J. Pept. Protein Res. 1990, 36, 255-266.
41. Wang, J. B.; Johnson, P. S.; Wu, J. M.; Wang, W. F.; Uhl, G. R. Human Kappa Opiate Receptor Second Extracellular Loop Elevates Dynorphin's Affinity for Human Mu/Kappa Chimeras. J. Biol. Chem. 1994, 269, 25966-25969.
42. Yasuda, K.; Raynor, K.; Kong, H.; Breder, C. D.; Takeda, J.; Reisine, T.; Bell, G. I. Cloning and Functional Comparison of Kappa and Delta Opioid Receptors from Mouse Brain. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 6736-6740.
43. Knapp, R. J.; Malatynska, E.; Collins, N.; Fang, L.; Wang, J. Y.; Hruby, V. J.; Roeske, W. R.; Yamamura, H. I. Molecular Biology and Pharmacology of Cloned Opioid Receptors. FASEB J. 1995, 9, 516-525.
44. Vig, B. S. Synthesis and Pharmacological Evaluation of Dynorphin A Analogs Constrained in the "Message" Sequence. Doctoral Dissertation. University of Maryland Baltimore, 2001.
45. Brugos, B.; Arya, V.; Hochhaus, G. Stabilized Dynorphin Derivatives for Modulating Antinociceptive Activity in Morphine Tolerant Rats: Effect of Different Routes of Administration. AAPS J. 2004, 6, e36. (Pubitemid 41554274)
46. Aldrich, J. V.; Patkar, K. A.; Chappa, A. K.; Fang, W.; Audus, K. L.; Lunte, S. M.; Carey, A. N.; McLaughlin, J. P. Development of Centrally Acting Peptide Analogs: Structure-Transport Studies and Pharmacological Evaluation of Analogs of the Opioid Peptide Dynorphin A. In Proceedings of the 4th International Peptide Symposium; Wilce, J., Ed.; Cairns, Queensland, Australia, 2007; www.peptideoz.org, M 64.
47. Aldrich, J. V.; Patkar, K. A.; McLaughlin, J. P. Zyklophin, a Systemically Active KappaOpioidReceptor Peptide Antagonist with Short Duration of Action, Proc. Natl. Acad. Sci. U.S.A., in press.
48. Vig, B. S.; Aldrich, J. V. An Inexpensive, Manually Operated, Solid-Phase, Parallel Synthesizer. Aldrichimica Acta 2004, 37, 2.
49. Vojkovsky, T. Detection of Secondary Amines on Solid Phase. Pept. Res. 1995, 8, 236-237.